Insilico's candidate demonstrated a favorable profile with good in vivo efficacy at low doses, efficient synthesis, and no need for…

EUA is based on data that show children 5 through 11 years of age had a robust immune response with a favorable safety profile following a 10-µg…

Based on topline data, three doses of the Pfizer-BioNTech COVID-19 Vaccine met all immunobridging criteria required for Emergency Use…

The report published by Economist Impact and sponsored by Daiichi Sankyo Europe, confirms that people who have tested positive for COVID-19 are…

Labs Across Canada Can Now Gain Speed, Cost-Efficient Scalability, and Consistency in a Hands-Free Swab Processing Workflow Rhinostics, Inc., an…

Shionogi & Co., Ltd. (hereafter “Shionogi”) announced new results from two late-breaking presentations of S-217622 at the 32nd European Congress…

Validation on saliva supports ultra-high throughput and compliance testing markets SpeeDx Pty. Ltd., a developer of innovative molecular…

Nearly 75% of American drivers plan to avoid public transit by driving to work in light of the COVID-19 pandemic SpotHero, a parking reservation…

− Nuvaxovid Intramuscular Injection, containing Matrix-MTM adjuvant, is the first recombinant protein-based COVID-19 vaccine approved for use in Japan…

Coronavirus has reshaped how businesses use their data networks. Now, as COVID-19 restrictions lift and evolve in Colorado and across the country,…